Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (Q4)Mar 31, 2020 | (Q3)Dec 31, 2019 | (Q2)Sep 30, 2019 | (Q1)Jun 30, 2019 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 50.32%72.96B | -12.78%48.54B | 7.54%55.65B | 1.96%51.74B | 36.44%50.75B | 10.38B | 280.02%8.69B | 61.60%16.81B | 81.39%14.87B | 18.26%37.2B |
Net profit before non-cash adjustment | -8.94%32.88B | -6.70%36.11B | -39.34%38.71B | 173.92%63.81B | 9.65%23.29B | --4.23B | 10.12%6.09B | 29.08%8.68B | 7.25%4.29B | 18.31%21.24B |
Total adjustment of non-cash items | -3.79%17.95B | 23.36%18.65B | 209.45%15.12B | -183.31%-13.82B | 18.45%16.58B | --7.73B | 22.63%3.24B | 2.31%3.72B | 20.83%1.89B | -14.96%14B |
-Depreciation and amortization | 27.46%22B | 6.12%17.26B | 8.85%16.26B | -1.67%14.94B | 28.26%15.2B | --4.07B | 29.37%3.82B | 9.21%3.28B | 37.94%4.02B | -1.69%11.85B |
-Reversal of impairment losses recognized in profit and loss | 8.01%634M | 56.53%587M | -57.82%375M | -37.66%889M | 55.68%1.43B | --1.11B | -47.90%62M | ---- | ---- | -44.15%916M |
-Share of associates | -5.88%-90M | 23.42%-85M | 99.61%-111M | -33,441.18%-28.51B | ---85M | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | 93.57%-16M | 91.47%-249M | -73,100.00%-2.92B | --4M | --0 | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | -500.96%-4.58B | -24.52%1.14B | 232.72%1.51B | -2,525.53%-1.14B | -96.20%47M | --2.63B | -57.11%-674M | -40.64%222M | -128.79%-2.13B | -71.50%1.24B |
Changes in working capital | 455.33%22.13B | -441.82%-6.23B | 4.11%1.82B | -83.91%1.75B | 458.60%10.88B | ---1.58B | 89.18%-637M | 12,136.11%4.41B | 230.09%8.69B | 165.62%1.95B |
-Change in receivables | 400.61%9.93B | -48.65%1.98B | 516.93%3.86B | -96.84%626M | 1,837.83%19.82B | ---1.51B | 293.94%8.44B | -34.97%-9.19B | 24.71%22.08B | 128.85%1.02B |
-Change in inventory | 146.05%4.53B | -797.99%-9.84B | 73.42%-1.1B | -203.57%-4.12B | 27.67%3.98B | --5.45B | 20.68%-9.86B | 372.00%6.58B | 811.56%1.81B | 192.36%3.12B |
-Change in prepaid assets | 172.79%2.05B | -2,279.07%-2.81B | -56.57%129M | --297M | ---- | ---- | ---- | ---- | ---- | ---- |
-Change in payables | 76.08%-271M | -570.41%-1.13B | -103.97%-169M | 134.03%4.26B | -255.19%-12.52B | ---7.47B | -48.43%5.46B | -15.84%4.42B | 3.52%-14.92B | -222.96%-3.52B |
-Change in accrued expense | 153.20%507M | -226.37%-953M | -87.18%-292M | 79.06%-156M | -1,321.31%-745M | --90M | ---- | ---- | -311.82%-233M | --61M |
-Provision for loans, leases and other losses | -74.16%23M | 103.75%89M | -229.44%-2.37B | -218.42%-720M | -52.05%608M | --2.14B | -634.32%-1.26B | -169.65%-218M | -161.18%-52M | 16.33%1.27B |
-Changes in other current assets | -23.82%4.91B | 265.85%6.44B | 12.32%1.76B | 667.75%1.57B | ---276M | ---- | ---- | ---- | ---- | ---- |
-Changes in other current liabilities | --461M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -26.96%-763M | 6.97%-601M | 10.53%-646M | 16.34%-722M | -73.64%-863M | -156M | -32.43%-196M | -229.89%-287M | -27.27%-224M | 31.07%-497M |
Interest received (cash flow from operating activities) | 1.90%376M | -4.40%369M | -10.85%386M | 108.17%433M | 271.43%208M | 20M | 300.00%52M | 450.00%22M | 225.71%114M | -34.88%56M |
Tax refund paid | -5.01%-14.38B | -9.61%-13.69B | -28.11%-12.49B | 13.15%-9.75B | -40.95%-11.23B | -122M | -26.24%-4.67B | 250.00%30M | -51.24%-6.46B | -52.14%-7.97B |
Other operating cash inflow (outflow) | -1M | 0 | 0 | -1M | 0 | 0 | 0 | 150.00%1M | -200.00%-1M | 0 |
Operating cash flow | 68.14%58.2B | -19.31%34.61B | 2.86%42.9B | 7.30%41.7B | 35.00%38.87B | --10.12B | 350.32%3.88B | 60.97%16.58B | 119.21%8.3B | 12.54%28.79B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 6.10%-4.39B | 62.12%-4.67B | -205.60%-12.33B | -11.71%-4.03B | 17.69%-3.61B | ---550M | 35.54%-963M | -31.71%-976M | -59.38%-1.12B | -25.95%-4.39B |
Net intangibles purchase and sale | -28.37%-1.69B | -27.79%-1.32B | -8.54%-1.03B | -12.32%-948M | -42.09%-844M | ---129M | -72.73%-285M | -54.26%-199M | -75.00%-231M | 18.41%-594M |
Net business purchase and sale | 89.34%-7.94B | -1,258.15%-74.42B | 1,181.82%6.43B | -960.71%-594M | 97.30%-56M | --0 | ---- | ---- | ---- | -155.03%-2.08B |
Net investment product transactions | 97.22%-20M | -104.10%-720M | 5,596.75%17.55B | 102.33%308M | -131.17%-13.21B | --3M | -151.23%-14.35B | --1.2B | ---56M | -503.91%-5.71B |
Net changes in other investments | 20.45%-105M | 91.68%-132M | -18.45%-1.59B | -4,563.33%-1.34B | 161.22%30M | --83M | 4,869.23%620M | -442.59%-370M | 34.56%-303M | 85.37%-49M |
Investing cash flow | 82.61%-14.14B | -999.99%-81.26B | 236.66%9.03B | 62.65%-6.61B | -37.97%-17.69B | ---593M | -103.62%-15.04B | 42.43%-346M | -94.55%-1.71B | -646.22%-12.82B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -198.77%-38B | 316.51%38.47B | 31.34%-17.77B | -35.48%-25.88B | -447.75%-19.1B | ---8.56B | 65.29%8.71B | -161.39%-19.32B | 112.82%74M | 78.76%-3.49B |
Net common stock issuance | 62.33%-504M | -87.92%-1.34B | 80.69%-712M | -944.48%-3.69B | 73.74%-353M | --378M | 29.78%-1.13B | 197.62%250M | 84.62%144M | -0.90%-1.34B |
Increase or decrease of lease financing | -17.97%-4.46B | -31.78%-3.78B | -20.26%-2.87B | 4.37%-2.38B | ---2.49B | ---706M | ---667M | ---517M | ---603M | ---- |
Cash dividends paid | -11.72%-2.86B | -7.29%-2.56B | -14.05%-2.39B | -12.05%-2.09B | -12.33%-1.87B | --0 | -18.38%-1.01B | --0 | -5.94%-856M | -18.71%-1.66B |
Net other fund-raising expenses | 107.95%14M | -104.67%-176M | 23,656.25%3.77B | 96.60%-16M | -237.83%-470M | ---579M | -116.90%-306M | 120.75%317M | 108.51%98M | 367.12%341M |
Financing cash flow | -249.60%-45.8B | 253.37%30.62B | 41.38%-19.96B | -40.25%-34.06B | -294.72%-24.28B | ---9.47B | 21.12%5.6B | -118.11%-19.27B | 9.29%-1.14B | 67.75%-6.15B |
Net cash flow | ||||||||||
Beginning cash position | -29.90%35.76B | 175.50%51B | 7.80%18.51B | -17.17%17.17B | 89.12%20.73B | --17.27B | 66.03%22.41B | 103.74%25.74B | 89.12%20.73B | 74.71%10.96B |
Current changes in cash | 89.14%-1.74B | -150.15%-16.03B | 2,976.03%31.96B | 133.46%1.04B | -131.63%-3.11B | --56M | -29.06%-5.56B | -453.19%-3.04B | 230.90%5.44B | 104.99%9.82B |
Effect of exchange rate changes | 21.31%945M | 46.98%779M | 77.26%530M | 166.00%299M | -906.67%-453M | ---153M | 2,576.47%421M | -9,700.00%-288M | -1,765.38%-433M | 54.55%-45M |
Cash adjustments other than cash changes | 0.00%1M | 0.00%1M | 0.00%1M | 200.00%1M | 50.00%-1M | --1M | --0 | ---1M | ---1M | 0.00%-2M |
End cash Position | -2.22%34.96B | -29.90%35.76B | 175.50%51B | 7.80%18.51B | -17.17%17.17B | --17.17B | 88.29%17.27B | 66.03%22.41B | 103.74%25.74B | 89.12%20.73B |
Free cash flow | 82.07%52.12B | -3.08%28.63B | -19.56%29.54B | 6.71%36.72B | 44.54%34.41B | --9.44B | 181.91%2.63B | 63.36%15.4B | 135.48%6.94B | 11.40%23.81B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |